Literature DB >> 23914302

Integrating Imaging Data into Predictive Biomathematical and Biophysical Models of Cancer.

Thomas E Yankeelov1.   

Abstract

While there is a mature literature on biomathematical and biophysical modeling in cancer, many of the existing approaches are not of clinical utility, as they require input data that are extremely difficult to obtain in an intact organism, and/or require a large number of assumptions on the free parameters included in the models. Thus, there has only been very limited application of such models to solve problems of clinical import. More recently, however, there has been increased activity at the interface of quantitative, noninvasive imaging data, and tumor mathematical modeling. In addition to reporting on bulk tumor morphology and volume, emerging imaging techniques can quantitatively report on for example tumor vascularity, glucose metabolism, cell density and proliferation, and hypoxia. In this paper, we first motivate the problem of predicting therapy response by highlighting some (acknowledged) shortcomings in existing methods. We then provide introductions to a number of representative quantitative imaging methods and describe how they are currently (and potentially can be) used to initialize and constrain patient specific mathematical and biophysical models of tumor growth and treatment response, thereby increasing the clinical utility of such approaches. We conclude by highlighting some of the exciting research directions when one integrates quantitative imaging and tumor modeling.

Entities:  

Year:  2012        PMID: 23914302      PMCID: PMC3729405          DOI: 10.5402/2012/287394

Source DB:  PubMed          Journal:  ISRN Biomath        ISSN: 2090-7702


  83 in total

1.  Effects of cell volume fraction changes on apparent diffusion in human cells.

Authors:  A W Anderson; J Xie; J Pizzonia; R A Bronen; D D Spencer; J C Gore
Journal:  Magn Reson Imaging       Date:  2000-07       Impact factor: 2.546

2.  Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.

Authors:  Y Fujibayashi; H Taniuchi; Y Yonekura; H Ohtani; J Konishi; A Yokoyama
Journal:  J Nucl Med       Date:  1997-07       Impact factor: 10.057

3.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

4.  Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.

Authors:  W J Koh; J S Rasey; M L Evans; J R Grierson; T K Lewellen; M M Graham; K A Krohn; T W Griffin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

Review 5.  Role of positron emission tomography in the early prediction of response to chemotherapy in patients with non--small-cell lung cancer.

Authors:  Evangelia Skoura; Ioannis E Datseris; Ioannis Platis; Georgios Oikonomopoulos; Konstantinos N Syrigos
Journal:  Clin Lung Cancer       Date:  2011-12-01       Impact factor: 4.785

Review 6.  Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

Authors:  J P Holland; J S Lewis; F Dehdashti
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-04       Impact factor: 2.346

Review 7.  An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response.

Authors:  Benjamin Titz; Robert Jeraj
Journal:  Phys Med Biol       Date:  2008-08-01       Impact factor: 3.609

8.  Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma.

Authors:  Thomas Cazaentre; Franck Morschhauser; Maximilien Vermandel; Nacim Betrouni; Thierry Prangère; Marc Steinling; Damien Huglo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-30       Impact factor: 9.236

9.  Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.

Authors:  Mindy D Szeto; Gargi Chakraborty; Jennifer Hadley; Russ Rockne; Mark Muzi; Ellsworth C Alvord; Kenneth A Krohn; Alexander M Spence; Kristin R Swanson
Journal:  Cancer Res       Date:  2009-04-14       Impact factor: 12.701

10.  Biocomputing: numerical simulation of glioblastoma growth using diffusion tensor imaging.

Authors:  Pierre-Yves Bondiau; Olivier Clatz; Maxime Sermesant; Pierre-Yves Marcy; Herve Delingette; Marc Frenay; Nicholas Ayache
Journal:  Phys Med Biol       Date:  2008-01-15       Impact factor: 3.609

View more
  5 in total

1.  Three-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy.

Authors:  Jared A Weis; Michael I Miga; Thomas E Yankeelov
Journal:  Comput Methods Appl Mech Eng       Date:  2016-09-01       Impact factor: 6.756

2.  Prior to Initiation of Chemotherapy, Can We Predict Breast Tumor Response? Deep Learning Convolutional Neural Networks Approach Using a Breast MRI Tumor Dataset.

Authors:  Richard Ha; Christine Chin; Jenika Karcich; Michael Z Liu; Peter Chang; Simukayi Mutasa; Eduardo Pascual Van Sant; Ralph T Wynn; Eileen Connolly; Sachin Jambawalikar
Journal:  J Digit Imaging       Date:  2019-10       Impact factor: 4.056

3.  Integrating a dynamic central metabolism model of cancer cells with a hybrid 3D multiscale model for vascular hepatocellular carcinoma growth.

Authors:  Alexey Lapin; Holger Perfahl; Harsh Vardhan Jain; Matthias Reuss
Journal:  Sci Rep       Date:  2022-07-20       Impact factor: 4.996

Review 4.  Machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy.

Authors:  Roberto Lo Gullo; Sarah Eskreis-Winkler; Elizabeth A Morris; Katja Pinker
Journal:  Breast       Date:  2019-11-23       Impact factor: 4.380

5.  Integrating in vitro experiments with in silico approaches for Glioblastoma invasion: the role of cell-to-cell adhesion heterogeneity.

Authors:  M-E Oraiopoulou; E Tzamali; G Tzedakis; E Liapis; G Zacharakis; A Vakis; J Papamatheakis; V Sakkalis
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.